Bayer AG (BSE:BAYN) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSE:BAYN Bayer AG BSE:BAYN
71 GF Score
Price lei249.20
GF Value lei138.65
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bayer AG Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BSE:BAYN
71GF Score
Bayer AG BSE:BAYN
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bayer AG (BSE:BAYN) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of lei249.20 is trading 79.7% above its estimated GF Value™ of lei138.65. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for BSE:BAYN:

  • Short Ratio:
  • GF Value™: lei138.65 vs. price of lei249.20 (79.7% above fair value)
  • GF Score™: 71/100 with 7 warning signs

No single metric tells the full story. See the BSE:BAYN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
71GF Score

Get the complete analysis for BSE:BAYN

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei249.20
Price
lei138.65
GF Value